The short isoforms were overexpressed in breast cancer cells and tissues and exhibited their oncogenic properties partly by causing activation of mTORC1 and increases in 4E-BP1 phosphorylation, cap-dependent translation and Mcl-1 levels. This evidence concerns the gene EIF4EBP1 and breast carcinoma.